Entreprise
Mineralys Therapeutics
Mineralys Therapeutics is a publicly traded, clinical-stage biotechnology company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Our initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that we are developing for cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease.
Mineralys is a fully remote company.
For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn.
Postes ouverts
144
en ligne maintenant
Nouveaux aujourd'hui
131
dernières 24 heures
Télétravail mondial
0
de n’importe où
Services
11
en recrutement
Aucun poste correspondant
Aucun poste ouvert chez Mineralys Therapeutics ne correspond à ces filtres pour le moment.